Biodesix
BDSX
Biodesix (BDSX) news
Recent news
Biodesix advances tumor-informed MRD program with Bio-Rad
AInvest Wire · Sep 24, 2026Biodesix advances two complementary approaches to molecular residual disease (MRD) monitoring
AInvest Wire · Sep 24, 2026BioDex: for FY 2026, co sees adj EBITDA continued improvement on path to profitability
Biodesix, Inc. (Nasdaq: BDSX) reported its first-quarter 2026 financial results, highlighting continued growth and operational improvements. The company generated $25.6 million in revenue for the quarter, reflecting a 42% year-over-year increase . This growth was driven by a 29% rise in diagnostic…
AInvest Wire · Aug 5, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.